Overview

A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants

Status:
NOT_YET_RECRUITING

Trial end date:
2026-05-08

Target enrollment:

Participant gender:

Summary

Evaluate the pharmacokinetic effects of itraconazole, fluconazole, or efavirenz on a single - dose of Clifutinib and the safety of the combination therapy in healthy participants.

Phase:

PHASE1

Details

Lead Sponsor:

Sunshine Lake Pharma Co., Ltd.

Treatments:

efavirenz
Fluconazole
Itraconazole